Rainbow by Dr Susan Ozer
A short story which provides some useful insight into ADHD in girls. The book aims to improve self-esteem and confidence.
Flynn Pharma Ltd funded the authoring, illustration, design and printing of this educational resource for parents.
Related Resources
‘ART’ – the ADHD Referral Toolkit – is a primary care toolkit designed to improve the quality of ADHD referrals to secondary care. This resource is available to all UK primary care clinicians. In this video Dr Jeremy Mudunkotuwe,  Consultant Psychiatrist, Surrey and Borders NHS Foundation Trust and Dr Nina Champaneri, Consultant Child and Adolescent Psychiatrist, in the Forward-Thinking Birmingham Crisis and Home Treatment Team provide information on the tool’s availability and its applicability for primary care.
A training resource for psychiatrists to facilitate identification of adult ADHD. Flynn Pharma, in conjunction with Virtual Health Shed, has developed 3D characters in a virtual environment to simulate interaction between the learner and a virtual patient or clinical virtual actor (avatar).
Despite its prevalence, ADHD in adults often goes unrecognised and remains under-diagnosed.
An Integrated Care Pathway document for the management of ADHD patients throughout their ADHD journey. Created in association with UK healthcare professionals to guide the patient journey through their ADHD diagnosis.
Tips leaflet for parents of children with ADHD affected by bullying. The leaflet discusses how to identify and deal with the impact of bullying.
Information for parents wanting to know more about ADHD and coordination difficulties. The leaflet describes Developmental Coordination Disorder (DCD) or dyspraxia and advises on referral, assessment and management.
This leaflet is a guide on safe driving, explaining ADHD and the risks, DVLA requirements, medication effects and tips on practical safety.
Tips on breakfast preparation, healthy diet and why it’s the most important meal of the day.
A fictional story about the importance of sleep aimed at children with ASD and ADHD aged 7 -11 years.
The leaflet considers the factors associated with poor sleep in children and adolescents with autism and provides tips and information on how to monitor sleep, how to take Slenyto and what to expect from treatment.